These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2315912)

  • 21. Reassessing benzene cancer risks using internal doses.
    Cox LA; Ricci PF
    Risk Anal; 1992 Sep; 12(3):401-10. PubMed ID: 1410709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro conjugation of benzene metabolites by human liver: potential influence of interindividual variability on benzene toxicity.
    Seaton MJ; Schlosser P; Medinsky MA
    Carcinogenesis; 1995 Jul; 16(7):1519-27. PubMed ID: 7614685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow DNA adducts and bone marrow cellularity following treatment with benzene metabolites in vivo.
    Hedli CC; Snyder R; Witmer CM
    Adv Exp Med Biol; 1991; 283():745-8. PubMed ID: 2069051
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of quinol thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity.
    Bratton SB; Lau SS; Monks TJ
    Chem Res Toxicol; 1997 Aug; 10(8):859-65. PubMed ID: 9282834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of exposure regimen and duration on benzene-induced bone-marrow damage in mice. I. Sex comparison in DBA/2 mice.
    Luke CA; Tice RR; Drew RT
    Mutat Res; 1988 Aug; 203(4):251-71. PubMed ID: 3405235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.
    Ramsey JC; Andersen ME
    Toxicol Appl Pharmacol; 1984 Mar; 73(1):159-75. PubMed ID: 6710512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of protein adducts to investigate the disposition of reactive metabolites of benzene.
    Rappaport SM; McDonald TA; Yeowell-O'Connell K
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1235-7. PubMed ID: 9118898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species differences in the metabolism of benzene.
    Henderson RF
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1173-5. PubMed ID: 9118889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In utero and acute exposure to benzene: investigation of DNA double-strand breaks and DNA recombination in mice.
    Lau A; Belanger CL; Winn LM
    Mutat Res; 2009 May; 676(1-2):74-82. PubMed ID: 19486867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologically based pharmacokinetic modeling of benzene metabolism in mice through extrapolation from in vitro to in vivo.
    Cole CE; Tran HT; Schlosser PM
    J Toxicol Environ Health A; 2001 Mar; 62(6):439-65. PubMed ID: 11289318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results.
    Spear RC; Bois FY
    Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):61-6. PubMed ID: 7737043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic effects of benzene: dosimetric studies on rats exposed to benzene vapour.
    Styles JA; Richardson CR
    Mutat Res; 1984 Mar; 135(3):203-9. PubMed ID: 6708961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicompartment liver-based pharmacokinetic model for benzene and its metabolites in mice.
    Manning CC; Schlosser PM; Tran HT
    Bull Math Biol; 2010 Apr; 72(3):507-40. PubMed ID: 20041354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and chronic dose/response effect of benzene inhalation on the peripheral blood, bone marrow, and spleen cells of CD-1 male mice.
    Green JD; Snyder CA; LoBue J; Goldstein BD; Albert RE
    Toxicol Appl Pharmacol; 1981 Jun; 59(2):204-14. PubMed ID: 7256764
    [No Abstract]   [Full Text] [Related]  

  • 36. Accumulation of low molecular weight (bleomycin detectable) iron in bone marrow cells of rats after benzene exposure.
    Pandya KP; Rao GS; Khan S; Krishnamurthy R
    Arch Toxicol; 1990; 64(4):339-42. PubMed ID: 1696804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene.
    Keys DA; Bruckner JV; Muralidhara S; Fisher JW
    Toxicol Sci; 2003 Nov; 76(1):35-50. PubMed ID: 12915716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of benzene toxicity by an interferon inducer (6MFA).
    Pandya KP; Shanker R; Gupta A; Khan WA; Ray PK
    Toxicology; 1986 Jun; 39(3):291-305. PubMed ID: 3705090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amifostine protects bone marrow from benzene-induced hematotoxicity in mice.
    Yu K; Yang KY; Ren XZ; Chen Y; Liu XH
    Int J Toxicol; 2007; 26(4):315-23. PubMed ID: 17661222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A calibrated human PBPK model for benzene inhalation with urinary bladder and bone marrow compartments.
    Knutsen JS; Kerger BD; Finley B; Paustenbach DJ
    Risk Anal; 2013 Jul; 33(7):1237-51. PubMed ID: 23278103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.